A novel activity for substance P: stimulation of peroxisome proliferator‐activated receptor‐γ protein expression in human monocytes and macrophages
Open Access
- 1 May 2008
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 154 (1), 144-152
- https://doi.org/10.1038/bjp.2008.50
Abstract
Background and purpose: Substance P (SP) and peroxisome proliferator‐activated receptor‐γ (PPAR‐γ) play important roles in different inflammatory conditions and are both expressed in human monocytes and macrophages. However, it is not known whether or not they interact. This study was undertaken to evaluate the effects of SP on PPAR‐γ protein expression in monocytes and macrophages (MDMs: monocyte‐derived macrophages) from healthy smokers and non‐smokers. Experimental approach: PPAR‐γ protein was detected by western blot and quantified by calculating the ratio between PPAR‐γ and β‐actin protein expression. Constitutive tachykinin NK1 receptor expression in monocytes and MDMs from healthy smokers and non‐smokers was evaluated by western blot. Cytokine release was evaluated by ELISA. Key results: In the concentration range 10−10–10−6 M, SP stimulated PPAR‐γ protein expression in monocytes and MDMs, being more effective in cells from healthy smokers. Moreover, in these cells there was a constitutively increased expression of NK1 receptors. SP‐induced expression of the PPAR‐γ protein was receptor‐mediated, as it was reproduced by the NK1 selective agonist [Sar9Met(O2)11]SP and reversed by the competitive NK1 antagonist GR71251. SP‐induced maximal effects were similar to those evoked by 15‐deoxy‐Δ12,14‐prostaglandin J2; an endogenous PPAR‐γ agonist, and were significantly reduced by a PPAR‐γ antagonist. NK1 and PPAR‐γ agonists exerted opposite effects on TNF‐α release from monocytes and MDMs. Conclusions and implications: Enhancement of PPAR‐γ protein expression represents a novel activity for SP, which could contribute to a range of chronic inflammatory disorders.Keywords
This publication has 42 references indexed in Scilit:
- Quantification of PPAR-γ protein in monocyte/macrophages from healthy smokers and non-smokers: A possible direct effect of nicotineLife Sciences, 2007
- Macrophage‐stimulating protein differently affects human alveolar macrophages from smoker and non‐smoker patients: evaluation of respiratory burst, cytokine release and NF‐κB pathwayBritish Journal of Pharmacology, 2006
- Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammationEuropean Journal of Pharmacology, 2006
- NF-κB Activation Precedes Increases in mRNA Encoding Neurokinin-1 Receptor, Proinflammatory Cytokines, and Adhesion Molecules in Dextran Sulfate Sodium–Induced Colitis in RatsDigestive Diseases and Sciences, 2005
- Expression of functional NK1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF‐κB pathwayBritish Journal of Pharmacology, 2005
- The role of substance P in microvascular responses in murine joint inflammationBritish Journal of Pharmacology, 2005
- The role of substance P in inflammatory diseaseJournal of Cellular Physiology, 2004
- Distinct pathways of LPS-induced NF-κB activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAPBlood, 2004
- PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDLCell, 1998
- Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγCell, 1998